Effect of Evogliptin on the Progression of Aortic Valvular Calcification
Get every episode summarized
Each time JACC This Week publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
About this episode
In the September 17, 2024 issue of JACC, Dr. Jai Quan Song and colleagues explore whether the DPP-4 inhibitor, abrogating, can slow the progression of aortic valvular calcification. Although the primary endpoint was not met, the study's promising secondary results and ongoing research into related therapies suggest potential future breakthroughs in medical treatment for aortic stenosis.
Get every episode summarized
Each time JACC This Week publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from JACC This Week
Season 2 Wrap-Up: Thank You, Reflections, and What Comes Next | JACC This Week
JACC This Week
March 31, 2026: Global Cardiovascular Insights & Breakthroughs from China | JACC...
JACC This Week
March 24, 2026: Cardiometabolic Health, COVID Impact & Prevention Science | JACC...
JACC This Week
March 17, 2026: Heart Failure, Chagas Research & AI in Cardiology | JACC This We...
JACC This Week